These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24810849)

  • 21. Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India.
    Maurya AK; Singh AK; Kant S; Umrao J; Kumar M; Kushwaha RA; Nag VL; Dhole TN
    Indian J Med Microbiol; 2013; 31(3):230-6. PubMed ID: 23883707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of drug-resistant tuberculosis.
    Chiang CY; Schaaf HS
    Int J Tuberc Lung Dis; 2010 Jun; 14(6):672-82. PubMed ID: 20487603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
    Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia.
    Skenders GK; Holtz TH; Riekstina V; Leimane V
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1546-52, i. PubMed ID: 22008771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic investigational new drugs for the treatment of tuberculosis.
    Kwon YS; Koh WJ
    Expert Opin Investig Drugs; 2016; 25(2):183-93. PubMed ID: 26576631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay.
    Ramos E; Fissette K; de Rijk P; Palomino JC; Martin A
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):110-3. PubMed ID: 22236855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis.
    Rosales S; Pineda-García L; Andino N; Almendarez N; Membreño H; Hoffner SE
    Int J Tuberc Lung Dis; 2009 Dec; 13(12):1542-9. PubMed ID: 19919774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of multi-drug resistant tuberculosis: practitioner's view point.
    Prasad R
    Indian J Tuberc; 2007 Jan; 54(1):3-11. PubMed ID: 17455417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xpert® MTB/RIF diagnosed disseminated smear-negative MDR-TB in a sub-district hospital in India.
    Dorjee K; Salvo F; Dierberg KL
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1560-1. PubMed ID: 23044453
    [No Abstract]   [Full Text] [Related]  

  • 31. New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis.
    O'Grady J; Maeurer M; Mwaba P; Kapata N; Bates M; Hoelscher M; Zumla A
    Curr Opin Pulm Med; 2011 May; 17(3):134-41. PubMed ID: 21415753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
    Chang KC; Yew WW
    Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF.
    Weyer K; Mirzayev F; Migliori GB; Van Gemert W; D'Ambrosio L; Zignol M; Floyd K; Centis R; Cirillo DM; Tortoli E; Gilpin C; de Dieu Iragena J; Falzon D; Raviglione M
    Eur Respir J; 2013 Jul; 42(1):252-71. PubMed ID: 23180585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes?
    Jonsson G; Furin J
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):4-5. PubMed ID: 22236840
    [No Abstract]   [Full Text] [Related]  

  • 35. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.
    Cox H; Hughes J; Daniels J; Azevedo V; McDermid C; Poolman M; Boulle A; Goemaere E; van Cutsem G
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):441-8. PubMed ID: 24670700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MDR-TB and XDR-TB: drug resistance and treatment outcomes.
    Migliori GB; Sotgiu G; D'Arcy Richardson M; Centis R; Facchini A; Guenther G; Spanevello A; Lange C;
    Eur Respir J; 2009 Sep; 34(3):778-9. PubMed ID: 19720816
    [No Abstract]   [Full Text] [Related]  

  • 37. Direct rapid diagnosis of rifampicin-resistant M. tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB).
    Cirillo DM; Piana F; Frisicale L; Quaranta M; Riccabone A; Penati V; Vaccarino P; Marchiaro G
    New Microbiol; 2004 Jul; 27(3):221-7. PubMed ID: 15460524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug-resistant tuberculosis: resistance mechanisms and drug susceptibility of Mycobacterium tuberculosis].
    Katalinić-Janković V; Obrovac M
    Acta Med Croatica; 2004; 58(4):323-8. PubMed ID: 15700689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent developments in genomics, bioinformatics and drug discovery to combat emerging drug-resistant tuberculosis.
    Swaminathan S; Sundaramurthi JC; Palaniappan AN; Narayanan S
    Tuberculosis (Edinb); 2016 Dec; 101():31-40. PubMed ID: 27865394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multidrug-resistant tuberculosis: challenges of a global emergence].
    Comolet T
    Bull Soc Pathol Exot; 2015 Oct; 108(4):290-8. PubMed ID: 26289547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.